The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Nanostring Technologies, Inc. for an nCounter MAX Analysis system to be used for specialized genotyping in epidemiologic studies of Human Papillomavirus (HPV) at the Chronic Viral Disease Branch. Please see attached sole source document for more information.

This contract action is for (supplies/services) in which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-(1)(b)(2) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist at [email protected] by 12:00pm EST Wednesday, May 23, 2018.

Bid Protests Not Available